In this file
  1. Start with the published offer
  2. Build a complete payment picture
  3. Check the commitment behind the saving
  4. Make the clinical comparison match
  5. A practical quote request
  6. Read the connected files
  7. Source notes

Before budgeting for OrderlyMeds, identify the event that produces a charge: joining a care program, buying a prescription, renewing a package, or booking a consultation. Those events can happen on different dates.

The main pricing detail in the documents is: A two-month starter package does not establish the maintenance price. Below, we distinguish the published figures from calculations and items that still require a personal quote.

Start with the published offer

The starter offer totals $149 for two months of compounded semaglutide or $299 for two months of compounded tirzepatide. The corresponding averages are $74.50 and $149.50. The page limits starter treatment to eligible patients; these averages should not be carried forward into later refills.

OrderlyMeds distinguishes introductory treatment from continuing care and lists branded pathways separately. Its public process involves screening, provider contact, and pharmacy fulfillment after prescribing. Marketing benefits do not replace the individual medical decision.

Build a complete payment picture

Ask OrderlyMeds for a dated summary with four lines: the amount due at enrollment, any separate medicine charge, the amount due at the next refill, and the total obligation under the chosen term. If no prescription has been issued, ask which parts can change after clinical assessment.

Add required care and testing to medication before comparing providers. A price per dose, a price per four weeks, and a calendar-month subscription cannot be compared simply by placing their headline numbers together. Start with the same treatment period and then compare the money needed upfront.

Check the commitment behind the saving

No membership or setup fee is advertised, but that tells us little about whether a prepared prescription can be refunded. Ask when the next order becomes committed and what renewal arrangement applies after the starting package.

A prepaid discount exchanges flexibility for a lower stated average. Financing may spread payments while leaving the full obligation in place. Ask what happens if treatment stops, changes, or cannot be prescribed, and whether that affects the medicine payment, membership, or both.

Make the clinical comparison match

The site describes remote provider review and preparation by a pharmacy. A delivery estimate begins within that larger process and is not proof that a prescription will be approved or arrive by a personally chosen date.

Do not budget for a different route or a starter prescription merely because it is cheaper. The clinician determines the treatment; the financial comparison should then describe that actual product and the care that accompanies it.

A practical quote request

Do I qualify for the starter prescription, and what is the complete first post-starter refill quote?

The published telephone number for OrderlyMeds is (866) 971-5161. An email route appears at support@orderlymeds.com.

For questions about an existing bill, use the OrderlyMeds contact file and keep the charge date, statement description, and receipt available. Use secure channels for any treatment record.

Read the connected files

The OrderlyMeds provider file connects the cost details, support routes, and cancellation questions so that the same plan can be checked from more than one angle.

To compare several offers on the same basis, use the GLP-1 price worksheet. It separates a low initial payment from an affordable ongoing plan.

Source notes

Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.

  1. No Insurance GLP-1 and GLP-1/GIP Medication Cost CalculatorProvider-published information · Checked September 22, 2026
  2. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 22, 2026
This article is educational research, not personal medical advice. A treating clinician should assess your circumstances. Research limits · Commercial disclosure · Contact information